CERECOR

cerecor-logo

Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for immunologic, immuno-oncologic and rare genetic disorders. The company is advancing its clinical-stage pipeline of innovative therapies that address unmet patient needs within rare and orphan diseases. The company's rare disease pipeline includes CERC-801, CERC-802 and CERC-803, which are in development for congenital disorders of glycosylation and CERC-006, an oral mTORc... 1/c2 inhibitor in development for the treatment of complex lymphatic malformations. The company is also developing two monoclonal antibodies, CERC-002, and CERC-007. CERC-002 targets the cytokine LIGHT (TNFSF14) and is in clinical development for treatment of severe pediatric-onset Crohn's disease and COVID-19 acute respiratory distress syndrome. CERC-007 targets the cytokine IL-18 and is in clinical development for the treatment of Stillโ€™s disease (adult onset Stillโ€™s disease (AOSD) and systemic juvenile idiopathic arthritis (sJIA)) and multiple myeloma (MM). CERC-006, 801, 802 and 803 have all received Orphan Drug Designation and Rare Pediatric Disease Designation, which makes all four eligible for a priority review voucher upon FDA approval.

#SimilarOrganizations #People #Financial #Website #More

CERECOR

Industry:
Biopharma Biotechnology Health Care

Founded:
2011-01-01

Address:
Baltimore, Maryland, United States

Country:
United States

Website Url:
http://www.cerecor.com

Total Employee:
11+

Status:
Active

Contact:
410-522-8707

Email Addresses:
[email protected]

Total Funding:
133.34 M USD

Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail IPv6 ReCAPTCHA ASP.NET Amazon Virginia Region ReCAPTCHA V2


Similar Organizations

not_available_image

AcSentient

AcSentient develops and commercializes specialty, niche prescription drugs.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

Current Employees Featured

h-jeffrey-wilkins_image

H. Jeffrey Wilkins
H. Jeffrey Wilkins Chief Medical Officer @ Cerecor
Chief Medical Officer
2020-02-01

not_available_image

Federica F. O&s;Brien
Federica F. O'Brien CFO @ Cerecor
CFO

phil-gutry_image

Phil Gutry
Phil Gutry Member of the Board of Director, Chair - Audit Committee @ Cerecor
Member of the Board of Director, Chair - Audit Committee
2015-04-01

james-harrell_image

James Harrell
James Harrell CCO @ Cerecor
CCO

Founder


blake-m-paterson_image

Blake M. Paterson

not_available_image

Isaac Blech

Stock Details


Company's stock symbol is NASDAQ:CERC

Acquisitions List

Date Company Article Price
2019-12-05 Aevi Genomic Medicine Aevi Genomic Medicine acquired by Cerecor 22.6 M USD
2018-09-25 Ichorion Therapeutics Ichorion Therapeutics acquired by Cerecor 26.6 M USD
2017-11-17 Zylera Pharmaceuticals Zylera Pharmaceuticals acquired by Cerecor N/A

Investors List

horizon-technology-finance_image

Horizon Technology Finance

Horizon Technology Finance investment in Post-IPO Debt - Cerecor

horizon-technology-finance_image

Horizon Technology Finance

Horizon Technology Finance investment in Post-IPO Debt - Cerecor

national-institutes-of-health_image

National Institutes of Health

National Institutes of Health investment in Grant - Cerecor

mpm-capital_image

MPM Capital

MPM Capital investment in Series B - Cerecor

apple-tree-partners_image

Apple Tree Partners

Apple Tree Partners investment in Series B - Cerecor

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series B - Cerecor

Official Site Inspections

http://www.cerecor.com

  • Host name: aec037177372cc6cd.awsglobalaccelerator.com
  • IP address: 15.197.225.128
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Cerecor"

Cerecor - Crunchbase Company Profile & Funding

Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for immunologic, immuno-oncologic and rare genetic โ€ฆSee details»

About CereCore

When an organization is expanding and adding new facilities, CereCore can support that growth. Outsourcing the help desk to them has allowed us to focus on things like our root cause โ€ฆSee details»

Cerecor, Inc. Information - RocketReach

Cerecor Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of prescription pharmaceuticals whose primary activity is in the human โ€ฆSee details»

Cerecor - 2025 Company Profile, Funding & Competitors - Tracxn

May 31, 2025 Cerecor has raised a total funding of $45.2M over 6 rounds. Its first funding round was on Apr 04, 2012. Its latest funding round was a Post IPO round on Apr 28, 2017 for $5M. โ€ฆSee details»

Cerecor and Aevi Genomic Medicine Complete Merger

Cerecor seeks to initiate a pivotal study for one or more CERC-800 program(s) in 2020, with the first anticipated NDA filing in 2021. About Cerecor . Cerecor is a biopharmaceutical company โ€ฆSee details»

Cerecor: Revenue, Worth, Valuation & Competitors 2025

About Cerecor. Cerecor is a Biotech related company with 33 employees an estimated revenue of $2.6M, and. It has 10 competitors including Dermavant Sciences, Metrum Research Group โ€ฆSee details»

Cerecor - VentureRadar

Cerecor Inc. ('Cerecor') is a Baltimore-based biopharmaceutical company developing innovative treatments to make a difference in the lives of patients suffering from neuropsychiatric โ€ฆSee details»

Parallon Technology Solutions is Now CereCore

The word โ€œCereCoreโ€ represents the unique impact the company has empowering caregivers to provide life-saving care. The name is comprised of two terms โ€ฆSee details»

Cerecor - Contacts, Employees, Board Members, Advisors & Alumni

Cerecor discovers, develops and commercializes neuroscience drugs. Experience the new Crunchbase, powered by AISee details»

Avalo Therapeutics, Inc. Announces Corporate Name Change

August 26, 2021 07:30 ET | Source: Cerecor Inc. Cerecor Inc. Name change underscores the Companyโ€™s transition to developing innovative targeted therapies in immunology, immuno โ€ฆSee details»

Cerecor Announces Drawdown of $10 Million Tranche under its โ€ฆ

Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for immunologic, immuno-oncologic and rare genetic โ€ฆSee details»

Leadership Team :: Avalo Therapeutics, Inc. (AVTX)

Dr. Neil serves as Chief Executive Officer at Avalo Therapeutics (formerly Cerecor, Inc.), a publicly held biotechnology company since February 2022. ... Under his leadership, his teams โ€ฆSee details»

Cerecor Reports 2020 Financial Results and Provides Business โ€ฆ

Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases. The company is advancing its โ€ฆSee details»

Cerecor - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Apr 27, 2025 The intellectual property of Cerecor includes 6 registered patents primarily in the ' Medical Or Veterinary Science; Hygiene ' category, according to IPqwery. Additionally, โ€ฆSee details»

Cerecor - Funding, Financials, Valuation & Investors - Crunchbase

Cerecor is registered under the ticker NASDAQ:CERC . Cerecor is funded by 6 investors. Horizon Technology Finance and Horizon Technology Finance are the most recent investors. Cerecor โ€ฆSee details»

Leadership and History | CereCore

Leadership with Healthcare Experience CereCore has hundreds of experts working across the nation with backgrounds in healthcare operations, clinical applications, technology, and data โ€ฆSee details»

What is Cerecor? Company Culture, Mission, Values | Glassdoor

See what employees say it's like to work at Cerecor. Salaries, reviews, and more - all posted by employees working at Cerecor.See details»

CereCore 2025 Company Profile: Overview & Executives - PitchBook

CereCore General Information Description. Provider of information technology services intended to aid the healthcare industry based out of United States. The company's offerings include โ€ฆSee details»

Working At Cerecor: Company Overview and Culture - Zippia

Learn about working at Cerecor from employee reviews and detailed data on culture, salaries, demographics, management, financial, and more. Find out what it's like to work at Cerecor. โ€ฆSee details»

Cerecor Announces Changes to Board of Directors - GlobeNewswire

Apr 24, 2020 These statements are based upon the current beliefs and expectations of Cerecorโ€™s management but are subject to significant risks and uncertainties, including: reliance โ€ฆSee details»

linkstock.net © 2022. All rights reserved